FDA.reportPublic FDA data

belladonna alkaloids / caffeine / ergotamine / pentobarbital

RxCUI
1007893
RxNorm name
belladonna alkaloids / caffeine / ergotamine / pentobarbital
Term type
MIN
Status
Active
Updated
2026-10-29 05:59:13

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
092010
Active start
092010
Multiple ingredient
YES
Branded
NO

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
belladonna alkaloids1359
caffeine1886
ergotamine4025
pentobarbital8004

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
RXNAV_STRbelladonna alkaloids / caffeine / ergotamine / PENTobarbital1NAMES
RxNorm Namebelladonna alkaloids / caffeine / ergotamine / pentobarbital1NAMES
TTYMIN1ATTRIBUTES
RxCUI10078931CODES
MMSL_CODEGNd034611CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN05CABarbiturates, plainATC1-4pentobarbital
ATCN02CAErgot alkaloidsATC1-4ergotamine
ATCD11AXOther dermatologicalsATC1-4caffeine
ATCN06BCXanthine derivativesATC1-4caffeine
FDASPLD004879ErgotaminesCHEMhas_chemical_structureergotamine
FDASPLD014970XanthinesCHEMhas_chemical_structurecaffeine
FDASPLN0000175739Central Nervous System StimulantEPChas_epccaffeine
FDASPLN0000175766Ergotamine DerivativeEPChas_epcergotamine
FDASPLN0000175790MethylxanthineEPChas_epccaffeine
FDASPLN0000175729Central Nervous System StimulationPEhas_pecaffeine
MEDRTD001393AzolesCHEMci_chemclassergotamine
MEDRTD001533Belladonna AlkaloidsCHEMhas_ingredientbelladonna alkaloids
MEDRTD002110CaffeineCHEMhas_ingredientcaffeine
MEDRTD004878ErgotamineCHEMhas_ingredientergotamine
MEDRTD018942MacrolidesCHEMci_chemclassergotamine
MEDRTD010424PentobarbitalCHEMhas_ingredientpentobarbital
MEDRTD000402Airway ObstructionDISEASEci_withpentobarbital
MEDRTD000437AlcoholismDISEASEci_withbelladonna alkaloids
MEDRTD001049ApneaDISEASEmay_treatcaffeine
MEDRTD001249AsthmaDISEASEci_withbelladonna alkaloids
MEDRTD003027Cluster HeadacheDISEASEmay_treatergotamine
MEDRTD003327Coronary DiseaseDISEASEci_withergotamine
MEDRTD004342Drug HypersensitivityDISEASEci_withcaffeine
MEDRTD004342Drug HypersensitivityDISEASEci_withergotamine
MEDRTD004342Drug HypersensitivityDISEASEci_withpentobarbital
MEDRTD005221FatigueDISEASEmay_treatcaffeine
MEDRTD005767Gastrointestinal DiseasesDISEASEmay_treatbelladonna alkaloids
MEDRTD005901GlaucomaDISEASEci_withbelladonna alkaloids
MEDRTD006261HeadacheDISEASEmay_treatbelladonna alkaloids
MEDRTD006973HypertensionDISEASEci_withergotamine
MEDRTD007674Kidney DiseasesDISEASEci_withbelladonna alkaloids
MEDRTD007674Kidney DiseasesDISEASEci_withergotamine
MEDRTD008107Liver DiseasesDISEASEci_withbelladonna alkaloids
MEDRTD008107Liver DiseasesDISEASEci_withergotamine
MEDRTD017093Liver FailureDISEASEci_withpentobarbital
MEDRTD008593MenopauseDISEASEmay_treatbelladonna alkaloids
MEDRTD008881Migraine DisordersDISEASEmay_treatergotamine
MEDRTD016491Peripheral Vascular DiseasesDISEASEci_withergotamine
MEDRTD011164PorphyriasDISEASEci_withpentobarbital
MEDRTD011247PregnancyDISEASEci_withpentobarbital
MEDRTD011247PregnancyDISEASEci_withergotamine
MEDRTD012640SeizuresDISEASEci_withbelladonna alkaloids
MEDRTD018805SepsisDISEASEci_withergotamine
MEDRTD013035SpasmDISEASEmay_treatbelladonna alkaloids
MEDRTD013226Status EpilepticusDISEASEmay_treatpentobarbital
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moaergotamine
MEDRTN0000000125Cholinergic Muscarinic AntagonistsMOAhas_moabelladonna alkaloids
MEDRTN0000190114Cytochrome P450 3A InhibitorsMOAhas_moaergotamine
MEDRTN0000182141Cytochrome P450 3A4 InhibitorsMOAci_moaergotamine
MEDRTN0000000203Dopamine Receptor InteractionsMOAhas_moaergotamine
MEDRTN0000000133Enzyme InhibitorsMOAhas_moacaffeine
MEDRTN0000000105Neurotransmitter Transporter InteractionsMOAhas_moapentobarbital
MEDRTN0000000130Serotonin AntagonistsMOAhas_moaergotamine
MEDRTN0000008322BronchodilationPEhas_pecaffeine
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pecaffeine
MEDRTN0000008351Cerebral Arterial VasoconstrictionPEhas_peergotamine
MEDRTN0000008567Decreased Collecting Duct Water PermeabilityPEhas_pecaffeine
MEDRTN0000008701Decreased Medullary Respiratory DrivePEci_pebelladonna alkaloids
MEDRTN0000008768Decreased Organized Electrical ActivityPEhas_pepentobarbital
MEDRTN0000008779Decreased Parasympathetic Acetylcholine ActivityPEhas_pebelladonna alkaloids
MEDRTN0000008868Decreased Respiratory SecretionsPEhas_pebelladonna alkaloids
MEDRTN0000175975General AnesthesiaPEhas_pepentobarbital
MEDRTN0000009197Increased Central Nervous System Organized Electrical ActivityPEhas_pecaffeine
MEDRTN0000009705Increased Uterine Smooth Muscle Contraction or TonePEhas_peergotamine
MEDRTN0000009808Positive ChronotropyPEhas_pebelladonna alkaloids
MEDRTN0000009820Pupillary DilationPEhas_pebelladonna alkaloids
MEDRTN0000009842Salivation InhibitionPEhas_pebelladonna alkaloids

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
CODESVUID4022408
NAMESTallman Synonymbelladonna alkaloids / caffeine / ergotamine / PENTobarbital
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceVeterans Health Administration National Drug File